March 10, 2026

Disclaimer: The information provided here is for educational purposes only and is not intended as medical advice. It should not be used to diagnose, treat, cure, or prevent any medical condition. Instead, use it as a starting point for discussion with your healthcare provider. Always consult with a qualified healthcare provider before starting any new medication, supplement, device, or making changes to your health regimen.
Months or even years into a chronic illness journey, many patients find themselves sitting perfectly still, only to feel their heart suddenly pounding as if they just ran a marathon. Heart palpitations—the uncomfortable, sometimes terrifying awareness of your own heartbeat—are among the most frequently reported and deeply distressing symptoms for individuals living with complex chronic conditions. For many, these episodes are accompanied by shortness of breath, dizziness, and a profound sense of anxiety, leading to urgent trips to the emergency room. Yet, all too often, standard cardiology workups return 'normal' results, leaving patients feeling dismissed, confused, and questioning their own reality.
If you have been told your racing heart is 'just anxiety' or a panic attack, it is crucial to understand that your symptoms are real, measurable, and physiologically grounded. In conditions like Long COVID, Postural Orthostatic Tachycardia Syndrome (POTS), Mast Cell Activation Syndrome (MCAS), and broader dysautonomia, heart palpitations are rarely caused by structural heart damage. Instead, they are the downstream effect of a nervous system, immune system, or vascular system that is misfiring. This guide will explore the complex biology behind why your heart races, how this symptom manifests across different invisible illnesses, and the evidence-based strategies you can use to track and manage it effectively.
Heart palpitations are broadly defined as the conscious, often uncomfortable awareness of one's own heartbeat. For healthy individuals, this sensation might occur briefly after an intense workout, a sudden scare, or consuming too much caffeine. However, for those living with complex chronic illnesses, palpitations are frequently unprovoked, sustained, and severely debilitating. Patients often describe the sensation as their heart pounding forcefully against their chest wall, fluttering erratically like a bird trapped in their ribcage, or skipping beats in a way that takes their breath away. This is not merely a subtle fluttering; it is a profound physiological event that commands the body's full attention and disrupts normal functioning.
These episodes can occur while simply standing up to walk to the kitchen, after eating a meal, or even while lying perfectly still in bed. The unpredictability of these cardiac events creates a constant state of hypervigilance, as patients never know when their heart rate might suddenly spike to 130 beats per minute or higher without any physical exertion. This constant monitoring of one's own internal state is exhausting and drains the limited energy reserves that chronic illness patients fight so hard to maintain. The sheer physical force of the heartbeat can make it impossible to concentrate, sleep, or engage in normal daily activities, fundamentally altering a person's quality of life.
When a patient presents to an emergency room or a standard cardiology clinic with a racing heart, the immediate medical protocol is to rule out structural heart disease or life-threatening arrhythmias. Physicians will typically run an electrocardiogram (ECG), an echocardiogram, and perhaps a standard blood panel to check for markers of cardiac tissue damage, such as troponin. In the vast majority of cases involving Long COVID, POTS, and MCAS, these tests return completely normal results, which can be incredibly frustrating for the patient seeking answers. They are told their heart is perfectly healthy, yet they feel as though they are experiencing a cardiac emergency on a daily basis.
This diagnostic disconnect happens because the heart muscle itself is structurally sound and the internal electrical pathways are functioning exactly as they should under the circumstances. The dysfunction lies not within the heart, but within the autonomic nervous system (ANS) that controls it. The heart is merely the messenger, responding appropriately to chaotic signals sent by a dysregulated brain, inflamed blood vessels, or a hyperactive immune system. Understanding this distinction is the first critical step in validating the patient experience and shifting the diagnostic focus from structural cardiology to autonomic neurology and immunology. It requires a paradigm shift in how we view cardiovascular symptoms in the context of systemic chronic illness.
Because standard cardiac workups often fail to capture the underlying autonomic dysfunction, many patients are incorrectly diagnosed with severe anxiety, panic disorder, or somatic symptom disorder. It is true that a racing heart can trigger feelings of anxiety; after all, the brain is hardwired to interpret a rapid heartbeat as a signal of imminent danger. However, in chronic illness, the physiological tachycardia almost always precedes the psychological sensation of anxiety, creating a physical state of panic without an emotional trigger. Patients are left trying to explain that they were perfectly calm before their heart rate suddenly doubled upon standing.
When the body experiences an adrenergic surge—a massive release of adrenaline and noradrenaline to compensate for poor blood flow—it chemically induces a state of panic. Telling a patient with dysautonomia to 'just relax' or prescribing anti-anxiety medications without addressing the underlying autonomic or immunological triggers is not only ineffective but deeply invalidating. It places the burden of symptom management on the patient's mental state rather than addressing the measurable, physiological root causes of their cardiovascular distress. Acknowledging the biological reality of these palpitations is essential for providing compassionate, effective care and rebuilding trust between patients and the medical system.
To understand why the heart races in chronic illness, we must first examine the mechanics of an adrenergic surge. In a healthy body, the autonomic nervous system seamlessly balances the sympathetic (fight-or-flight) and parasympathetic (rest-and-digest) branches. When you stand up, gravity naturally pulls blood down into your lower extremities. Baroreceptors, which are specialized pressure sensors located in your blood vessels, instantly detect this drop in blood pressure and signal the brain to slightly increase the heart rate and constrict the blood vessels, ensuring a steady flow of oxygen to the brain. This process is usually so smooth that we never even notice it happening.
In conditions like Understanding Dysautonomia: When the Autonomic Nervous System Misfires, this precise communication system breaks down completely. Due to factors like low blood volume (hypovolemia) or damaged small nerve fibers (neuropathy), the blood vessels fail to constrict properly, leading to significant blood pooling in the legs and abdomen. To prevent you from fainting, the brain hits the panic button, triggering a massive release of catecholamines—specifically norepinephrine and epinephrine. This chemical flood binds directly to beta-1 adrenergic receptors in the heart, causing it to beat both unnaturally fast and abnormally hard, which patients feel as a terrifying, pounding palpitation. Research has shown that in hyperadrenergic forms of POTS, standing plasma norepinephrine levels can spike to exceptionally high levels, confirming the profound physiological nature of this response.
Another crucial, yet frequently overlooked, biological driver of heart palpitations is the immune system, specifically the role of mast cells. Mast cells are a type of white blood cell found throughout the body, including densely packed within cardiac tissue and surrounding blood vessels. They are the body's first line of defense, but in Mast Cell Activation Syndrome (MCAS), they become highly unstable and release chemical mediators inappropriately. When mast cells degranulate, they release a flood of histamine directly into the bloodstream, which has a profound and direct impact on cardiovascular function.
When histamine binds to H2 receptors on the heart muscle, it acts as a positive chronotrope and inotrope, directly forcing the heart to beat faster and contract more forcefully. Simultaneously, histamine binding to H1 receptors in the blood vessels causes massive vasodilation, or widening of the veins. This sudden drop in blood pressure forces the autonomic nervous system to trigger reflex tachycardia—a rapid heart rate designed to compensate for the sudden loss of vascular resistance. This dual action makes histamine a potent trigger for severe, sudden-onset palpitations that often mimic allergic reactions or panic attacks, as supported by recent clinical research on histamine blockade.
In the context of infection-associated chronic illnesses like Long COVID, the biology of palpitations becomes even more complex due to the direct impact of the virus on the vascular and nervous systems. SARS-CoV-2 has a high affinity for ACE2 receptors, which are abundant in the endothelial cells lining our blood vessels. When the virus binds to these receptors, it can cause widespread endothelial dysfunction and microvascular inflammation. This inflammation impairs the blood vessels' ability to dilate and constrict appropriately, further exacerbating the blood pooling that triggers reflex tachycardia. This vascular damage is a key reason why so many patients develop new-onset cardiovascular symptoms post-infection.
Additionally, emerging research suggests that the virus may exhibit neurotropism, meaning it can directly invade or inflame nervous system tissue. This includes potential damage to the vagus nerve, the primary superhighway of the parasympathetic nervous system. The vagus nerve is responsible for sending the 'calm down' signals to the heart, effectively acting as the body's natural brake pedal. When the vagus nerve is injured or inflamed, the sympathetic nervous system is left unchecked, leading to a persistent, elevated resting heart rate and a heightened susceptibility to palpitations from even minor physical or emotional stressors.
When discussing heart palpitations in the context of chronic illness, Heart Rate Spikes in POTS: Why Your Heart Races When You Stand Up is often the first condition that comes to mind. POTS is a specific form of dysautonomia clinically defined by an abnormal increase in heart rate of at least 30 beats per minute (or 40 bpm for adolescents) within 10 minutes of standing, without a corresponding drop in blood pressure. For these patients, the simple act of standing up against gravity is enough to trigger a severe adrenergic surge, leading to intense palpitations, dizziness, and profound fatigue.
Since the onset of the pandemic, a staggering number of individuals have developed debilitating heart palpitations as part of Long COVID. Accumulating clinical evidence indicates that these palpitations are rarely caused by structural heart damage, but are instead primarily driven by viral-induced dysautonomia. Studies have shown that a significant percentage of Long COVID patients develop POTS or POTS-like symptoms, driven by persistent inflammation, autoantibodies attacking autonomic receptors, and microvascular dysfunction. For many, these cardiovascular symptoms are among the most persistent and disabling aspects of their post-viral illness.
While typically associated with allergic-like reactions such as hives and gastrointestinal distress, MCAS is a major, yet under-recognized, cause of severe heart palpitations. Because mast cells are present in cardiac tissue and release potent vasodilators like histamine, an MCAS flare can cause sudden, unexplained tachycardia and blood pressure fluctuations. According to the American Academy of Allergy, Asthma & Immunology, tachycardia and hypotension are strictly recognized criteria for diagnosing systemic anaphylactic-like episodes in MCAS. Patients with MCAS often find that their palpitations are triggered by specific foods, environmental allergens, or stress, rather than just postural changes.
Beyond POTS, other forms of dysautonomia can also cause severe palpitations. Inappropriate Sinus Tachycardia (IST) is a condition where a patient's resting heart rate is abnormally high (often consistently over 100 bpm) and spikes dramatically with even minimal exertion, regardless of their physical position. Unlike POTS, which is primarily triggered by standing, IST patients may experience intense palpitations while sitting or lying down. This constant cardiovascular overdrive leaves patients feeling perpetually exhausted, as their heart is essentially running a marathon while their body is trying to rest.
Living with unpredictable heart palpitations fundamentally alters how a person navigates their daily life. Many patients report that the simple act of taking a warm shower—which causes blood vessels to dilate and exacerbates blood pooling—can trigger a heart rate spike so severe that they must lie down on the bathroom floor to avoid fainting. This phenomenon, known as orthostatic intolerance, turns mundane tasks like cooking a meal, standing in line at the grocery store, or folding laundry into monumental physical challenges. The constant need to monitor one's physical position and plan for potential cardiac episodes requires an immense amount of cognitive and emotional energy.
Because these symptoms are entirely invisible to the outside observer, patients frequently struggle to communicate the severity of their condition to friends, family, and employers. You might look perfectly healthy while sitting at a desk, but the moment you stand up to walk to a meeting, your heart rate may jump to 140 bpm, leaving you breathless and dizzy. This invisible burden often leads to profound social isolation, as patients may decline invitations or avoid public spaces out of fear that they will experience a severe palpitation episode without access to a safe place to lie down and recover.
Perhaps one of the most devastating impacts of chronic heart palpitations is the psychological toll of medical gaslighting. Research shows patients often experience significant delays in diagnosis, frequently being told by multiple specialists that their symptoms are purely psychosomatic. When a patient is repeatedly told that their terrifying, physically exhausting symptoms are 'all in their head,' it erodes their trust in the medical system and, tragically, their trust in their own body. This constant invalidation can lead to secondary medical trauma, making it even more difficult for patients to seek the care they desperately need.
For patients who also suffer from Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) or Long COVID, heart palpitations are often a warning sign of impending post-exertional malaise (PEM). PEM is a severe, disproportionate exacerbation of symptoms following minimal physical or cognitive exertion. Many patients describe their racing heart as the first indicator that they have pushed beyond their body's energy envelope. If they ignore this warning sign and continue to push through the fatigue, the palpitations often worsen, eventually leading to a debilitating crash that can leave them bedbound for days or weeks. Learning to listen to these cardiac cues is a crucial, albeit challenging, part of managing complex chronic illness.
In recent years, the intersection of chronic illness and wearable technology has revolutionized how patients measure and track their heart palpitations. Smartwatches and fitness trackers equipped with photoplethysmography (PPG) sensors and single-lead ECGs allow patients to monitor their heart rate and heart rate variability (HRV) continuously throughout the day. For individuals with POTS or Long COVID, these devices provide crucial objective data that validates their subjective experience. A recent large-scale smartwatch study demonstrated that wearables can accurately detect the persistent autonomic dysfunction and elevated resting heart rates characteristic of Long COVID, providing a powerful tool for both patients and researchers.
Furthermore, the Scripps Research Detect Study found that a subset of Long COVID patients maintained a significantly elevated resting heart rate for over 133 days post-infection. Many patients utilize specialized tracking apps, such as TachyMon or Visible, which are designed specifically for the chronic illness community. Unlike standard fitness apps that encourage users to 'push harder' and close their activity rings, these specialized tools provide custom alerts when the heart rate increases by a specific threshold or crosses a dangerous limit. This real-time feedback allows patients to implement a strategy called 'pacing'—stopping an activity and resting the moment their heart rate spikes, thereby preventing a severe symptom flare or PEM crash.
While wearables are excellent for daily tracking, formal clinical diagnosis of the underlying dysautonomia requires specific autonomic testing. The gold standard for diagnosing POTS is the Head-Up Tilt Table Test (HUTT) or the Active Stand Test (often referred to as the NASA Lean Test). During these assessments, a patient's heart rate and blood pressure are continuously monitored as they transition from a supine (lying down) position to an upright position. These tests objectively measure the body's cardiovascular response to orthostatic stress, capturing the exact moment the adrenergic surge and reflex tachycardia occur.
In addition to digital tracking, maintaining a detailed symptom diary is one of the most effective ways to identify the specific triggers for your heart palpitations. Because conditions like MCAS and Long COVID are highly individualized, what causes a severe cardiac episode in one patient may not affect another. Patients are encouraged to track not only their heart rate but also their daily fluid intake, sodium consumption, meals, sleep quality, and environmental exposures. Over time, patterns often emerge, revealing that palpitations may be linked to specific high-histamine foods, dehydration, changes in barometric pressure, or emotional stress. This granular level of tracking empowers patients to make targeted lifestyle modifications and provides invaluable clues for their medical care team.
For many patients with dysautonomia and POTS, the first-line defense against heart palpitations is aggressive volume expansion. Because hypovolemia (low blood volume) is a primary trigger for the compensatory adrenergic surge, increasing intravascular volume can significantly reduce the heart's need to race. Clinical management typically requires a dramatic increase in fluid intake—often 2.5 to 3 liters of water daily—paired with a high sodium intake of 5 to 10 grams per day. This combination helps the body retain water, increasing blood pressure and cerebral perfusion, which in turn signals the nervous system that it is safe to lower the heart rate.
Beyond sodium, maintaining a delicate balance of other essential minerals is critical for cardiac rhythm stability. Low levels of magnesium or potassium can increase the risk of irritable tachycardias and exacerbate autonomic dysfunction. Many patients find that targeted supplementation, such as exploring Can Magnesium Glycinate Support Energy and Calm the Nervous System in Long COVID and POTS?, helps soothe the nervous system and reduce the frequency of palpitations. Magnesium acts as a natural calcium channel blocker, helping to regulate the electrical impulses within the heart and supporting overall autonomic tone.
When a severe palpitation episode strikes, patients can utilize specific physical techniques known as vagal maneuvers to acutely stimulate the parasympathetic nervous system and slow the heart rate. The vagus nerve acts as the body's natural brake pedal, and stimulating it can help override the sympathetic overdrive. The modified Valsalva maneuver—which involves bearing down against a closed glottis for 10 to 15 seconds, followed immediately by lying flat and elevating the legs—has been shown to be highly effective in converting certain types of tachycardia back to a normal sinus rhythm. Other techniques, such as applying an ice pack to the chest or face, or engaging in deep, diaphragmatic paced breathing, can also help activate the vagus nerve and bring the heart rate down safely.
When lifestyle modifications and physical maneuvers are insufficient, targeted pharmacological interventions become necessary. For patients with hyperadrenergic POTS, sympatholytic medications like clonidine or beta-blockers may be prescribed to block the sympathetic output and prevent adrenaline from overstimulating the heart. Another increasingly utilized medication is Ivabradine, which selectively lowers the heart rate by inhibiting the sinus node's 'funny' channels without lowering blood pressure—a crucial benefit for dysautonomia patients prone to orthostatic hypotension.
For patients whose palpitations are driven by immune dysregulation, such as in MCAS, traditional cardiac medications may be ineffective or even worsen symptoms. Instead, the focus shifts to stabilizing the mast cells and blocking the effects of histamine. High doses of H1 and H2 antihistamines (such as fexofenadine and famotidine) can prevent histamine from binding to the vascular and cardiac receptors, effectively stopping the reflex tachycardia at its source. Additionally, exploring anti-inflammatory support, such as Can Omega-3s Calm Inflammation in Long COVID and MCAS?, may help reduce the overall systemic inflammatory burden that keeps the immune system in a hyper-reactive state.
In addition to medications, many patients benefit from targeted nutritional support to address the underlying mechanisms of their dysautonomia. For instance, supporting vascular health and circulation is paramount for reducing the blood pooling that triggers palpitations. Patients may explore options like Can Vessel Forte™ Support Circulation and Blood Pooling in POTS and Long COVID? to promote endothelial function. Furthermore, ensuring adequate levels of essential vitamins is crucial for immune and autonomic regulation; learning about Can Vitamin D3 Support Immune and Autonomic Function in Long COVID and POTS? can provide insights into how foundational nutrients play a role in stabilizing the body's complex physiological systems.
Living with chronic heart palpitations is an exhausting, frightening, and often isolating experience. If you have spent months or years navigating a medical system that dismisses your symptoms as mere anxiety, please know that your experience is valid. The sudden racing of your heart, the dizziness upon standing, and the profound exhaustion that follows are real, measurable physiological events driven by complex autonomic and immunological mechanisms. You are not imagining your symptoms, and you are not alone in this fight. The growing body of research surrounding Long COVID, POTS, and MCAS is finally bringing these invisible mechanisms to light, paving the way for better diagnostics and more targeted, compassionate care.
Managing complex chronic conditions requires a multidisciplinary approach and a care team that truly understands the nuances of dysautonomia and immune dysregulation. It is essential to work with healthcare providers who are willing to look beyond standard cardiology workups and explore the autonomic and immunological root causes of your palpitations. Always consult with a qualified healthcare professional before starting or stopping any medications, supplements, or intensive lifestyle interventions, as treatments must be carefully tailored to your specific physiological needs.
At RTHM, we are dedicated to providing the comprehensive, science-backed support you need to navigate the complexities of Long COVID, ME/CFS, POTS, and MCAS. By combining advanced diagnostics with personalized management strategies, we strive to help you regain control over your symptoms and improve your quality of life.
Pretorius, E., et al. (2024). Mechanisms of long COVID and the path toward therapeutics. Cell. https://www.sciencedirect.com/science/article/pii/S0092867424008869
Eldokla, A. M., et al. (2023). Prevalence and patterns of symptoms of dysautonomia in patients with long COVID syndrome. Frontiers in Cardiovascular Medicine. https://www.frontiersin.org/articles/10.3389/fcvm.2023.1202696/full
Pawlikowska, M., et al. (2025). Immunotherapies for postural orthostatic tachycardia syndrome, other common autonomic disorders, and Long COVID: current state and future direction. Frontiers in Cellular and Infection Microbiology. https://www.frontiersin.org/journals/cellular-and-infection-microbiology/articles/10.3389/fcimb.2025.1647203/full
American Academy of Allergy, Asthma & Immunology (AAAAI). Mast Cell Activation Syndrome (MCAS). https://www.aaaai.org/conditions-treatments/related-conditions/mcas
Journal of Hypertension. (2024). Complete remission with histamine blocker in a patient with intractable hyperadrenergic postural orthostatic tachycardia syndrome secondary to long coronavirus disease syndrome. https://journals.lww.com/jhypertension/fulltext/2024/05000/complete_remission_with_histamine_blocker_in_a.23.aspx
CSH Smartwatch Study. (2025). npj Digital Medicine. Investigating the physiological impact of COVID-19 and Long COVID using wearable technology. https://www.nature.com/articles/s41746-023-00782-2
Scripps Research Detect Study. JAMA Network Open. Prolonged physiological impact of COVID-19 on resting heart rate and autonomic function. https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2781725
Journal of the American Heart Association (JAHA). Mast Cell Activation Disorder and Postural Orthostatic Tachycardia Syndrome: A Clinical Association. https://www.ahajournals.org/doi/10.1161/JAHA.121.021002
PubMed. Highlights in cardiovascular effects of histamine and H1-receptor antagonists. https://pubmed.ncbi.nlm.nih.gov/9312845/
Dysautonomia International. Mast Cell Activation Syndrome vs POTS. https://thediekman.com/mast-cell-activation-syndrome-vs-pots/